NCI investigational drugs. Chemical information

LDR 01880cas a2200469 a 4500
001 011327010
003 MiAaHDL
005 20110215000000.0
006 m d
007 cr bn ---auaua
008 840921c19849999mduuu f f0 0eng d
010 ‡a 89658517 //r90 ‡zsn 84045796
019 ‡a11494986
035 ‡asdr-pur684675
035 ‡a684675
035 ‡9ADE2835PU
035 ‡a(OCoLC)11184006
040 ‡aCLU ‡cCLU ‡dNYG ‡dOCL ‡dNST ‡dDLC ‡dGPO ‡dm/c ‡dNST ‡dDLC ‡dGPO ‡dDLC ‡dIUL ‡dIPL
042 ‡alc
043 ‡an-us---
050 0 0 ‡aRS431.A64 ‡bN38
074 ‡a507-G-34 (MF)
082 0 0 ‡a615/.1901 ‡220
086 0 ‡aHE 20.3180/2:
092 ‡a615.1901 ‡bN213
096 ‡aQV 772 N335
245 0 0 ‡aNCI investigational drugs. ‡pChemical information.
246 1 0 ‡aChemical information
246 1 0 ‡aNational Cancer Institute investigational drugs. Chemical information
260 ‡a[Bethesda, Md.] : ‡bU.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, ‡c1984-
300 ‡av. : ‡bill. ; ‡c24 cm.
362 0 ‡a1984-
490 0 ‡aNIH publication
530 ‡aVols. for <1988-> distributed to depository libraries in microfiche.
538 ‡aMode of access: Internet.
550 ‡aVols. for 1984-<1992> prepared by the Pharmaceutical Resources Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute.
650 2 ‡aChemistry, Analytical ‡xhandbooks
650 2 ‡aDrugs ‡xhandbooks
650 0 ‡aDrugs ‡zUnited States ‡vPeriodicals.
650 0 ‡aPharmaceutical chemistry ‡vPeriodicals.
650 0 ‡aAntineoplastic agents ‡xStandards ‡vPeriodicals.
710 2 ‡aDevelopmental Therapeutics Program (U.S.). ‡bPharmaceutical Resources Branch.
710 2 ‡aNational Institutes of Health (U.S.)
866 4 1 ‡80 ‡a1984
866 4 1 ‡xwd:6-4-02/ra
CID ‡a011327010
DAT 0 ‡a20101013104903.0 ‡b20110215000000.0
DAT 1 ‡a20120815064345.0 ‡b2024-09-29T18:16:56Z
DAT 2 ‡a2024-09-29T17:30:02Z
CAT ‡aSDR-PUR ‡dUNKNOWN ‡lloader.pl-001-001
FMT ‡aSE
HOL ‡0sdr-pur684675 ‡apur1 ‡bSDR ‡cPUR ‡ppur1.32754075505291 ‡sPUR ‡z1984 ‡1684675
974 ‡bPUR ‡cPUR ‡d20240929 ‡sgoogle ‡upur1.32754075505291 ‡z1984 ‡y1984 ‡rpd ‡qbib ‡tUS fed doc